Biosenic Stock

Biosenic ROCE 2025

Biosenic ROCE

-0.66

Ticker

BIOS.BR

ISIN

BE0974280126

WKN

A14NHV

In 2025, Biosenic's return on capital employed (ROCE) was -0.66, a 0% increase from the 0 ROCE in the previous year.

Biosenic Aktienanalyse

What does Biosenic do?

Bone Therapeutics SA is a Belgian company specializing in the development of innovative therapies for bone and joint diseases. Its goal is to treat patients with severe orthopedic conditions and help improve their quality of life. The company's business model is based on extensive research and development strategies aimed at developing groundbreaking therapies for diseases such as fractures, osteoporosis, osteoarthritis, and other bone and joint-related conditions. It focuses on the development of innovative stem cell-based therapies that help repair damaged tissues and promote self-regeneration. Additionally, Bone Therapeutics has developed a special cell therapy called Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells, targeting cartilage growth as an alternative, cell-based therapy for knee and hip osteoarthritis. It has also developed a platform called Allogeneic Osteoblastic Cells, aiming to treat ligament and tendon injuries. The company conducts research and clinical studies in collaboration with academic partners to improve its therapies and develop new products and solutions. It operates in three business areas: Orthobiology, Cardiology, and Immunology, focusing on the development and marketing of therapies for bone and joint arthritis, cardiovascular diseases, and autoimmune diseases, respectively. Its current product offerings include Allob, AlgoScaff, and JTA-004 for the treatment of orthopedic conditions such as fractured vertebrae, severe bone injuries, bone regeneration, osteoporosis, and osteoarthritis. Bone Therapeutics is headquartered in Gosselies, Belgium, with offices in the US, France, Germany, and Italy. Its mission is to advance the development of therapies for bone and joint diseases and assist patients with severe orthopedic conditions. Through its research and development strategies, collaboration with academic partners, and strong market position, Bone Therapeutics aims to make a difference in the field. Biosenic ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Biosenic's Return on Capital Employed (ROCE)

Biosenic's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Biosenic's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Biosenic's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Biosenic’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Biosenic stock

What is the ROCE (Return on Capital Employed) of Biosenic this year?

The ROCE of Biosenic is -0.66 undefined this year.

How has the ROCE (Return on Capital Employed) of Biosenic developed compared to the previous year?

The ROCE of Biosenic has increased by 0% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Biosenic?

A high Return on Capital Employed (ROCE) indicates that Biosenic has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Biosenic?

A low ROCE (Return on Capital Employed) can indicate that Biosenic has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Biosenic impact the company?

An increase in the ROCE of Biosenic can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Biosenic affect the company?

A decrease in ROCE of Biosenic can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Biosenic?

Some factors that can affect Biosenic's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Biosenic so important for investors?

The ROCE of Biosenic is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Biosenic take to improve the ROCE?

To improve the ROCE, Biosenic can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Biosenic pay?

Over the past 12 months, Biosenic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biosenic is expected to pay a dividend of 0 EUR.

What is the dividend yield of Biosenic?

The current dividend yield of Biosenic is .

When does Biosenic pay dividends?

Biosenic pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biosenic?

Biosenic paid dividends every year for the past 0 years.

What is the dividend of Biosenic?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biosenic located?

Biosenic is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biosenic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biosenic from 7/3/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 7/3/2025.

When did Biosenic pay the last dividend?

The last dividend was paid out on 7/3/2025.

What was the dividend of Biosenic in the year 2024?

In the year 2024, Biosenic distributed 0 EUR as dividends.

In which currency does Biosenic pay out the dividend?

The dividends of Biosenic are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Biosenic

Our stock analysis for Biosenic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biosenic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.